MGRX
Mangoceuticals, Inc.
$0.36
-0.01 (-3.59%)
At close · Jul 8
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from date of issuance of this filing.”View the 10-Q filed May 19, 2026
Market Cap
$6.17M
Shares
17,167,422
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Revenue & result across quarters
Revenue ($B) YoY up YoY down artefacts
Earnings call
FY24 · Q2
2024-08-15
Mangoceuticals, Inc. Q2 FY2024 Earnings Call
Revenue
$163,163
▲ 15.5% YoY Diluted EPS
$-1.37
Gross margin
42.8%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-10-19
Mangoceuticals, Inc. Q3 FY2023 Earnings Call
Revenue
$245,160
Diluted EPS
$-1.70
Gross margin
59.0%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls